Loading...
 
Mediterr J Rheumatol 2020;31(Supp 2):253-6
Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic
Authors Information

1. 4th Department of Internal Medicine, Hipokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

2. Rheumatology and Clinical Immunology, University of Crete Medical School and University Hospital of Iraklio, Iraklio, Greece

Theodoros Dimitroulas, George Bertsias

References
  1. Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol 2017;28:4-12.
  2. Venerito V, Lopalco G, Iannone F. COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence. Rheumatol Int 2020;40:827-8.
  3. Sawalha AH, Manzi S. Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus. Eur J Rheumatol 2020;7:Supplement S117-S120.
  4. EULAR Guidance For Patients COVID-19 Outbreak. https://www.eular.Org/Eular_Guidance_For_Patients_Covid19_Outbreak.Cfm. 11. A Message from the ACR About Coronavirus Disease 2019 (COVID-19). https://www.Rheumatology.org/announcements12. British Society for Rheumatology (BSR): Covid-19 (Coronavirus) - Update for Members.
  5. https://www.Rheumatology.org.uk/News-Policy/Details/Covid19-Coronavirus-Update-Members
  6. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 May;8(5):475-81.
  7. The Greek Rheumatology Society and Professional Association of Rheumatologists - ERE-EPERE Recommendations Regarding COVID19 Infection in Rheumatic Patients in Greece Mediterr J Rheumatol 2020;31:6-7.
  8. Robinson PC, Yazdany J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat Rev Rheumatol 2020;16(6):293-4.
  9. Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, et al.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012;64:640-7.
  10. Castrejón I, Tani C, Jolly M, Huang A, Mosca M. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol 2014;32(5 Suppl 85):S85-95.
  11. https://www.rheumatology.org.uk/Portals/0/Documents/Rheumatology_advice_coronavirus_immunosuppressed_patients_220320.pdf?ver=2020-03-24-171132-407 
  12. Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun 2020;111:102468.
  13. https://www.health.gov.au/resources/publications/covid-19-national-health-plan-electronic-prescribing-a-guide-for-pharmacists
  14. https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/prescribing-and-dispensing/electronic/electronic-repeat-dispensing-erd
  15. Di Giambenedetto S, Ciccullo A, Borghetti A, Gambassi G, Landi F, Visconti E, et al.; GEMELLI AGAINST COVID-19 group (Members are listed in the Acknowledgments section). Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection. J Med Virol  2020;16:101002/jmv.25897.
  16. Owens B. Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology. Lancet Rheumatology 2020;2(5):e257.
  17. Bogdanos D, Daniil Z, Zakynthinos E, Gourgoulianis K, Sakkas L. When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients? Mediterr J Rheumatol 2020;31:94-7.
  18. Smolen JS. Treat to Target in Rheumatology: A Historical Account on Occasion of the 10th Anniversary. Rheum Dis Clin North Am 2019;45:477-85.
  19. Mohammadzadeh N, Safdari R. Patient monitoring in mobile health: opportunities and challenges. Med Arch 2014;68:57-60.
  20. Hetland ML, Krogh NS, Horslev-Petersen K, et al. Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry. Clin Exp Rheumatol 2016; 34(5 Suppl 101):S75-S78.
  21. Van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, et al. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open 2016 Nov 24;2:e000302.
  22. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting thetransmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020;368(6493):860-8.